Mitsubishi UFJ Asset Management Co. Ltd. Grows Position in Colgate-Palmolive Company $CL

Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in Colgate-Palmolive Company (NYSE:CL) by 5.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,724,756 shares of the company’s stock after acquiring an additional 93,730 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd. owned 0.21% of Colgate-Palmolive worth $137,877,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CL. Brighton Jones LLC increased its holdings in Colgate-Palmolive by 4.4% in the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after buying an additional 450 shares during the last quarter. Woodline Partners LP boosted its position in shares of Colgate-Palmolive by 76.3% during the 1st quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock worth $4,344,000 after acquiring an additional 20,062 shares in the last quarter. Schnieders Capital Management LLC. increased its holdings in shares of Colgate-Palmolive by 2.0% in the 2nd quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock valued at $1,136,000 after acquiring an additional 245 shares during the last quarter. Envestnet Asset Management Inc. raised its position in shares of Colgate-Palmolive by 0.4% during the 2nd quarter. Envestnet Asset Management Inc. now owns 678,352 shares of the company’s stock worth $61,662,000 after acquiring an additional 2,768 shares in the last quarter. Finally, Bessemer Group Inc. raised its position in shares of Colgate-Palmolive by 16.0% during the 2nd quarter. Bessemer Group Inc. now owns 19,264 shares of the company’s stock worth $1,751,000 after acquiring an additional 2,650 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insider Buying and Selling

In other news, insider Sally Massey sold 15,851 shares of the company’s stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the completion of the sale, the insider owned 13,751 shares in the company, valued at $1,306,757.53. This represents a 53.55% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO Panagiotis Tsourapas sold 35,000 shares of Colgate-Palmolive stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $94.61, for a total transaction of $3,311,350.00. Following the completion of the transaction, the chief operating officer owned 10,415 shares in the company, valued at approximately $985,363.15. This trade represents a 77.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 184,683 shares of company stock worth $17,486,693. 0.34% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. The Goldman Sachs Group reiterated a “buy” rating and issued a $100.00 price target on shares of Colgate-Palmolive in a research note on Friday, February 20th. Evercore upped their target price on shares of Colgate-Palmolive from $94.00 to $100.00 and gave the company an “outperform” rating in a report on Monday, February 2nd. UBS Group lifted their price target on shares of Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a research note on Wednesday, January 14th. Piper Sandler upped their price objective on shares of Colgate-Palmolive from $88.00 to $96.00 and gave the company an “overweight” rating in a research note on Friday, January 30th. Finally, Argus reiterated a “hold” rating on shares of Colgate-Palmolive in a research report on Thursday, December 11th. Eleven investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $94.75.

Colgate-Palmolive Trading Up 0.9%

Shares of Colgate-Palmolive stock opened at $97.50 on Friday. The company has a debt-to-equity ratio of 18.82, a quick ratio of 0.27 and a current ratio of 0.83. The company has a market capitalization of $78.59 billion, a P/E ratio of 37.21, a PEG ratio of 4.36 and a beta of 0.29. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $100.18. The company’s fifty day moving average is $87.08 and its two-hundred day moving average is $82.63.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The business had revenue of $5.23 billion during the quarter, compared to analysts’ expectations of $5.13 billion. During the same period in the prior year, the company earned $0.91 earnings per share. The business’s revenue was up 5.8% compared to the same quarter last year. Analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st were paid a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.1%. The ex-dividend date was Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is 79.39%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.